N
Neurocentria
CA - Walnut Creek
BiotechnologyFocus: Small molecule for neurological disorders
Neurocentria is a life sciences company focused on Small molecule for neurological disorders.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
NRCT-101SR, NRCT-202XR
ADHDClinical Trials (1)
NCT06673368A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
Phase 2MMFS-202-302
SchizophreniaClinical Trials (1)
NCT02237235Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
Phase 2Low Dose MMFS-205-SR
AnxietyClinical Trials (1)
NCT03601169Comparison of MMFS Dosages in Older Adults
Phase 2MMFS-205-SR
Alzheimer DiseaseClinical Trials (1)
NCT03531684Efficacy and Safety of MMFS in Early AD
Phase 2L-Threonic Acid Magnesium Salt
Attention Deficit/Hyperactivity DisorderClinical Trials (1)
NCT02558790L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD
Phase 2Phase 2/3
Clinical Trials (1)
NCT06215144Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
Phase 2/3NRCT-101-SR
ADHDClinical Trials (1)
NCT05683249Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2012
Portfolio: 7 clinical trials